keyword
https://read.qxmd.com/read/38650797/delayed-serotonin-syndrome-and-non-cardiogenic-pulmonary-edema-following-bupropion-overdose-in-a-seven-year-old-female-a-case-report-and-review-of-literature
#1
Madison P Craft, Kaitlyn Burdsall, Hanna S Sahhar
Bupropion is an atypical antidepressant prescribed for depression and attention-deficit/hyperactivity disorder and to aid in smoking cessation. Bupropion overdose management is largely aimed toward common sequelae, including seizures, tachycardia, and QTc prolongation. In this case report, we identify a rare event of pediatric bupropion overdose with aforementioned common sequela and atypical features, including a delayed presentation of serotonin syndrome and non-cardiogenic pulmonary edema. This case follows a seven-year-old Caucasian female with autism spectrum disorder (ASD) who presented in status epilepticus following an accidental bupropion overdose and required multiple anti-seizure medications, endotracheal intubation, and admission to the pediatric intensive care unit (PICU)...
March 2024: Curēus
https://read.qxmd.com/read/38639539/dopaminergic-modulation-and-computational-admet-insights-for-the-antidepressant-like-effect-of-n-3-phenylselanyl-prop-2-yn-1-yl-benzamide
#2
JOURNAL ARTICLE
Evelyn Mianes Besckow, Kauane Nayara Bahr Ledebuhr, Camila Simões Pires, Marcia Juciele da Rocha, Natália Emanuele Biolosor Kuntz, Benhur Godoi, Cristiani Folharini Bortolatto, César Augusto Brüning
The compound N -(3-(phenylselanyl)prop-2-yn-1-yl)benzamide (SePB), which combines a selenium atom and a benzamide nucleus in an organic structure, has demonstrated a fast antidepressant-like effect in mice. This action is influenced by the serotonergic system and represents a promising development in the search for novel antidepressant drugs to treat major depressive disorder (MDD), which often resists conventional treatments. This study aimed to further explore the mechanism underlying the antidepressant-like effect of SePB by investigating the involvement of the dopaminergic and noradrenergic systems in the tail suspension test (TST) in mice and evaluating its pharmacokinetic profile in silico...
April 19, 2024: ACS Chemical Neuroscience
https://read.qxmd.com/read/38634393/effectiveness-of-antidepressants-in-combination-with-psychotherapy
#3
JOURNAL ARTICLE
Farrokh Alemi, Tulay G Soylu, Mary Cannon, Conor McCandless
BACKGROUND: Consensus-guidelines for prescribing antidepressants recommend that clinicians should be vigilant to match antidepressants to patient's medical history but provide no specific advice on which antidepressant is best for a given medical history. AIMS OF THE STUDY: For patients with major depression who are in psychotherapy, this study provides an empirically derived guideline for prescribing antidepressant medications that fit patients' medical history...
March 1, 2024: Journal of Mental Health Policy and Economics
https://read.qxmd.com/read/38630213/italian-guidelines-for-the-management-of-adult-individuals-with-overweight-and-obesity-and-metabolic-comorbidities-that-are-resistant-to-behavioral-treatment
#4
JOURNAL ARTICLE
M Chianelli, L Busetto, R Vettor, B Annibale, A Paoletta, E Papini, A Albanese, M Carabotti, D Casarotto, G De Pergola, O E Disoteo, I Grandone, G Medea, E Nisoli, M Raffaelli, S Schiff, F Vignati, M Cinquini, M Gonzalez-Lorenzo, V A Fittipaldo, S Minozzi, M Monteforte, A C Tralongo, R Novizio, A Persichetti, I Samperi, A Scoppola, G Borretta, M Carruba, M G Carbonelli, M De Luca, S Frontoni, S G Corradini, F Muratori, R Attanasio
AIM: This guideline (GL) is aimed at providing a clinical practice reference for the management of adult patients with overweight or obesity associated with metabolic complications who are resistant to lifestyle modification. METHODS: Surgeons, endocrinologists, gastroenterologists, psychologists, pharmacologists, a general practitioner, a nutritionist, a nurse and a patients' representative acted as multi-disciplinary panel. This GL has been developed following the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach...
April 17, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38628555/efficacy-of-bupropion-and-varenicline-genetic-markers-in-choosing-pharmacological-treatment-for-smoking-cessation-and-implications-for-combining-drugs-a-randomized-controlled-trial-gentsmoking
#5
JOURNAL ARTICLE
Patricia V Gaya, Juliana R Santos, Paulo R X Tomaz, Tania M O Abe, Miguel Nassif, Larissa G Galas, Bianca B Bellini, Iana R Moraes, Paulo C Lima Santos, Paulo C R P Correa, Jaqueline R Scholz
INTRODUCTION: Smoking cessation is the best strategy for reducing tobacco-related morbimortality. The goal of this randomized controlled trial was to test whether using the genetically favorable markers to choose a smoking cessation drug treatment (precision medicine) was superior to using the most effective drug (varenicline) in terms of abstinence rates. Additionally, combination therapy was tested when monotherapy failed. METHODS: This partially blind, single-center study randomized (1:1) 361 participants into two major groups...
2024: Tobacco Induced Diseases
https://read.qxmd.com/read/38627068/a-critical-view-on-new-and-future-antidepressants
#6
REVIEW
Alessandro Serretti
For the first time after many decades, many new antidepressants have been approved and many more are under various stages of development and will soon be available in the market. The new drugs present a range of new mechanisms of action with benefits in terms of speed of action, tolerability and range of treatable disorders. Neurosteroids have been recently approved and their rapid benefit may extend from postpartum depression to anxious depression and bipolar depression, dextromethorphan and bupropion combination may prove useful in major depression but also in treatment resistant depression, dextromethadone is a possible augmentation in partial antidepressant response, psychedelic drugs have the potential of long lasting benefits after a single administration, though are still experimental treatments...
May 31, 2024: Clinical Psychopharmacology and Neuroscience: the Official Scientific Journal of the Korean College of Neuropsychopharmacology
https://read.qxmd.com/read/38623136/electrocardiographic-effects-of-bupropion-toxicity-suggesting-dysfunction-of-the-gap-junction-or-connexin-43
#7
Patrick Bruss, Ryan Hartle, Jennifer Astacio, Ammar F Chauhdri
This is a case of a 20-year-old pregnant female presenting EKG abnormalities associated with an overdose of bupropion. These ECG abnormalities are prolongation of the QRS, prolongation of the corrected QT interval (QTc), right axis deviation, and a terminal R wave. The propagation of electricity through the myocardium is dependent on many factors. It is dependent on the flow of sodium from the extracellular to intracellular space, flow of potassium from intracellular to extracellular space, and ultimately the propagation of the signal at the gap junction by Connexin 43 (Cx-43)...
March 2024: Curēus
https://read.qxmd.com/read/38613082/food-cravings-and-obesity-in-women-with-polycystic-ovary-syndrome-pathophysiological-and-therapeutic-considerations
#8
REVIEW
Katerina Stefanaki, Dimitrios S Karagiannakis, Melpomeni Peppa, Andromachi Vryonidou, Sophia Kalantaridou, Dimitrios G Goulis, Theodora Psaltopoulou, Stavroula A Paschou
Polycystic ovary syndrome (PCOS), the most common endocrine disorder in women of reproductive age, constitutes a metabolic disorder frequently associated with obesity and insulin resistance (IR). Furthermore, women with PCOS often suffer from excessive anxiety and depression, elicited by low self-esteem due to obesity, acne, and hirsutism. These mood disorders are commonly associated with food cravings and binge eating. Hypothalamic signaling regulates appetite and satiety, deteriorating excessive food consumption...
April 3, 2024: Nutrients
https://read.qxmd.com/read/38606851/discordance-between-insurance-coverage-of-antiviral-medications-and-nicotine-replacement-therapy-among-individuals-with-human-immunodeficiency-virus-who-smoke
#9
JOURNAL ARTICLE
Steven L Bernstein, Jessica E Yager, Keith Sigel, Elizabeth Porter, Tina Do, Erika Payne, Krysten Bold, David Ledgerwood, E Jennifer Edelman
INTRODUCTION: Tobacco contributes to the leading causes of morbidity and mortality among persons with human immunodeficiency virus (PWHs). Nonetheless, medications for tobacco use disorder are widely underused, particularly among PWHs. We sought to characterize the extent to which insurance barriers impacted access to medications for tobacco use disorder and, in comparison, to access to antiretroviral therapy (ART). METHODS: This is a secondary analysis of data on individuals enrolled in a randomized clinical trial to address tobacco use involving nicotine replacement therapy and, for some, additionally, varenicline or bupropion...
April 12, 2024: Journal of Addiction Medicine
https://read.qxmd.com/read/38597366/common-pitfalls-in-the-use-of-hypertonic-sodium-bicarbonate-for-cardiac-toxic-drug-poisonings
#10
JOURNAL ARTICLE
Betty S Chan, Nicholas A Buckley
BACKGROUND: Hypertonic sodium bicarbonate is advocated for the treatment of sodium channel blocker poisoning, but its efficacy varies amongst different sodium channel blockers. This Commentary addresses common pitfalls and appropriate usage of hypertonic sodium bicarbonate therapy in cardiotoxic drug poisonings. SODIUM BICARBONATE WORKS SYNERGISTICALLY WITH HYPERVENTILATION: Serum alkalinization is best achieved by the synergistic effect of hypertonic sodium bicarbonate and hyperventilation (PCO2 ∼ 30-35 mmHg [0...
April 10, 2024: Clinical Toxicology
https://read.qxmd.com/read/38596098/genetic-variants-haplotype-determination-and-function-of-novel-alleles-of-cyp2b6-in-a-han-chinese-population
#11
JOURNAL ARTICLE
Li-Qun Zhang, Xin-Yue Li, Lian-Guo Chen, Zhe Chen, Ren-Ai Xu, Jian-Chang Qian, Xiao-Yang Zhou, Da-Peng Dai, Guo-Xin Hu, Jian-Ping Cai
Amino acid variants in protein may result in deleterious effects on enzymatic activity. In this study we investigate the DNA variants on activity of CYP2B6 gene in a Chinese Han population for potential use in precision medicine. All exons in CYP2B6 gene from 1483 Chinese Han adults (Zhejiang province) were sequenced using Sanger sequencing. The effects of nonsynonymous variants on recombinant protein catalytic activity were investigated in vitro with Sf12 system. The haplotype of novel nonsynonymous variants with other single nucleotide variants in the same allele was determined using Nanopore sequencing...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38587055/suicide-ideation-and-male-female-differences-in-major-depressive-disorder
#12
JOURNAL ARTICLE
Paolo Olgiati, Basilio Pecorino, Alessandro Serretti
OBJECTIVE: This study aimed to explore male-female differences in suicide ideation (SI) and suicide risk factors in major depressive disorder (MDD). METHODS: We analysed 482 adults (sample 1) and 438 elderly outpatients (sample 2) with MDD. Sample 1 was treated with different antidepressant combinations (escitalopram; bupropion plus escitalopram; venlafaxine plus mirtazapine) and assessed by means of the Concise Health Risk Tracking (SI), Quick Inventory of Depressive Symptomatology, Altman Mania Rating Scale and Psychiatric Diagnostic Screening Questionnaire...
April 8, 2024: International Journal of Psychiatry in Clinical Practice
https://read.qxmd.com/read/38586907/correction-to-naltrexone-bupropion-mysimba-in-management-of-obesity-a-systematic-review-and-meta-analysis-of-unpublished-clinical-study-reports
#13
Igho J Onakpoya
No abstract text is available yet for this article.
April 8, 2024: British Journal of Clinical Pharmacology
https://read.qxmd.com/read/38582569/pharmacotherapy-for-adults-with-overweight-and-obesity-a-systematic-review-and-network-meta-analysis-of-randomised-controlled-trials
#14
JOURNAL ARTICLE
Qingyang Shi, Yang Wang, Qiukui Hao, Per Olav Vandvik, Gordon Guyatt, Jing Li, Zhe Chen, Shishi Xu, Yanjiao Shen, Long Ge, Feng Sun, Ling Li, Jiajie Yu, Kailei Nong, Xinyu Zou, Siyi Zhu, Cong Wang, Shengzhao Zhang, Zhi Qiao, Zhongyu Jian, Ya Li, Xinyi Zhang, Kerun Chen, Furong Qu, Yuan Wu, Yazhou He, Haoming Tian, Sheyu Li
BACKGROUND: Pharmacotherapy provides an option for adults with overweight and obesity to reduce their bodyweight if lifestyle modifications fail. We summarised the latest evidence for the benefits and harms of weight-lowering drugs. METHODS: This systematic review and network meta-analysis included searches of PubMed, Embase, and Cochrane Library (CENTRAL) from inception to March 23, 2021, for randomised controlled trials of weight-lowering drugs in adults with overweight and obesity...
April 6, 2024: Lancet
https://read.qxmd.com/read/38576145/addendum-bupropion-safety-in-pregnancy
#15
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 1, 2024: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/38576143/drugs-for-bipolar-disorder
#16
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 1, 2024: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/38570861/5-epifat-trial-protocol-a-multi-center-randomized-placebo-controlled-trial-of-the-efficacy-of-pharmacotherapy-for-fatigue-using-methylphenidate-bupropion-ginseng-and-amantadine-in-advanced-cancer-patients-on-active-treatment
#17
JOURNAL ARTICLE
Mojtaba Miladinia, Mina Jahangiri, Sharon Jackson White, Hossein Karimpourian, Alessandro Inno, Sally Wai-Chi Chan, Reza Ganji, Mahmood Maniati, Kourosh Zarea, Marziyeh Ghalamkari, Ali Farahat, Cecilia Fagerström
BACKGROUND: Cancer-related fatigue (CRF) is still undertreated in most patients, as evidence for pharmacological treatments is limited and conflicting. Also, the efficacy of the pharmacological agents relative to each other is still unclear. Therefore, medications that may potentially contribute to improving CRF will be investigated in this head-to-head trial. Our main objective is to compare the efficacy of methylphenidate vs. bupropion vs. ginseng vs. amantadine vs. placebo in patients with advanced cancer...
April 3, 2024: Trials
https://read.qxmd.com/read/38569181/serotonin-syndrome-and-dextromethorphan-toxicity-caused-by-drug-drug-interaction-between-fluoxetine-and-bupropion-dextromethorphan-a-case-report
#18
JOURNAL ARTICLE
Michelle Anjali Singh, Devon Johnson
No abstract text is available yet for this article.
April 3, 2024: Journal of Clinical Psychiatry
https://read.qxmd.com/read/38566910/exploring-the-association-between-weight-loss-inducing-medications-and-multiple-sclerosis-insights-from-the-fda-adverse-event-reporting-system-database
#19
JOURNAL ARTICLE
Afsaneh Shirani, Anne H Cross, Olaf Stuve
BACKGROUND: Several studies have demonstrated that early childhood and adolescent obesity are risk factors for multiple sclerosis (MS) susceptibility. Obesity is thought to share inflammatory components with MS through overproduction of pro-inflammatory adipokines (e.g., leptin) and reduction of anti-inflammatory adipokines (e.g, adiponectin). Recently, drug repurposing (i.e. identifying new indications for existing drugs) has garnered significant attention. The US Food and Drug Administration Adverse Event Reporting System (FAERS) database serves not only as a resource for mining adverse drug reactions and safety signals but also for identifying inverse associations and potential medication repurposing opportunities...
2024: Therapeutic Advances in Neurological Disorders
https://read.qxmd.com/read/38564922/sleep-related-adverse-events-of-smoking-cessation-drugs-a-network-meta-analysis-of-randomized-controlled-trials
#20
REVIEW
Yubin Song, Yoon-A Park, Da Hoon Lee, Jeong Yee, Hye Sun Gwak
Smoking cessation medications have the potential to affect the functioning of the nervous system, leading to sleep disturbances. Our study aimed to compare the sleep-related side effects (such as insomnia, abnormal dreams, nightmares, and somnolence) induced by different smoking cessation medications in non-psychiatric smokers. We conducted a thorough search of five electronic databases (Cochrane, EMBASE, PubMed, PsycInfo, and Web of Science) for randomized controlled trials. This study was registered with the PROSPERO (registration number CRD42022347976)...
March 29, 2024: Psychiatry Research
keyword
keyword
109274
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.